As trial miss threatens FDA approval, Travere points to Filspari's benefits in bid to stay in kidney disease 0 02.11.2023 23:48 Fiercepharma.com As trial miss threatens FDA approval, Travere points to Filspari's benefits in bid to stay in kidney disease aliu Thu, 11/02/2023 - 16:48 Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
